Leading global pharma companies call on governments to help fight AMR

21 January 2016

More than 80 leading pharmaceutical and diagnostics companies have joined forces to call on governments around the world to work with industry in the fight against drug-resistant infection.

Companies including Novartis, Pfizer, Merck, Johnson & Johnson, GlaxoSmithKline and Roche signed the ‘Declaration on Combating Antimicrobial Resistance,’ launched today (January 21) at the World Economic Forum in Davos, Switzerland.

The signatories call on governments to develop new economic models to support their vision, which is outlined in three main areas: reduce drug-resistant bacteria through appropriate use of new and existing antibiotics, increase investment and collaboration in research and development, and improve access to high-quality antibiotics.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK